These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16036096)

  • 41. Prevention and treatment of osteoporosis in women with breast cancer.
    Mincey BA; Moraghan TJ; Perez EA
    Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adult Premenopausal Bone Health Related to Reproductive Characteristics-Population-Based Data from the Canadian Multicentre Osteoporosis Study (CaM
    Goshtasebi A; Berger C; Barr SI; Kovacs CS; Towheed T; Davison KS; Prior JC
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29783670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High dietary sodium intake is associated with low bone mass in postmenopausal women: Korea National Health and Nutrition Examination Survey, 2008-2011.
    Kwon SJ; Ha YC; Park Y
    Osteoporos Int; 2017 Apr; 28(4):1445-1452. PubMed ID: 28074252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Premenopausal bone loss: fact or artifact?
    Riis BJ
    Osteoporos Int; 1994; 4 Suppl 1():35-7. PubMed ID: 8081056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stress urinary incontinence in premenopausal and postmenopausal women: evaluation of serum estradiol levels and bone mineral density.
    Ozbek E; Dursun M; Otunctemur A; Sami Cakir S; Can Polat E
    Minerva Ginecol; 2014 Jun; 66(3):293-8. PubMed ID: 24971784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
    Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteoporosis prevention, diagnosis, and therapy.
    NIH Consens Statement; 2000 Mar 27-29; 17(1):1-45. PubMed ID: 11525451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fractures before menopause: a red flag for physicians.
    Hosmer WD; Genant HK; Browner WS
    Osteoporos Int; 2002; 13(4):337-41. PubMed ID: 12030549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is heritability a risk factor for postmenopausal osteoporosis?
    Hansen MA; Hassager C; Jensen SB; Christiansen C
    J Bone Miner Res; 1992 Sep; 7(9):1037-43. PubMed ID: 1414496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
    Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levels of serum estradiol and lifestyle factors related with bone mineral density in premenopausal Mexican women: a cross-sectional analysis.
    Huitrón-Bravo G; Denova-Gutiérrez E; Talavera JO; Moran-Villota C; Tamayo J; Omaña-Covarrubias A; Salmerón J
    BMC Musculoskelet Disord; 2016 Oct; 17(1):437. PubMed ID: 27756278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression.
    Petronijević M; Petronijević N; Ivković M; Stefanović D; Radonjić N; Glisić B; Ristić G; Damjanović A; Paunović V
    Bone; 2008 Mar; 42(3):582-90. PubMed ID: 18226593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone Density After Teriparatide Discontinuation in Premenopausal Idiopathic Osteoporosis.
    Cohen A; Kamanda-Kosseh M; Recker RR; Lappe JM; Dempster DW; Zhou H; Cremers S; Bucovsky M; Stubby J; Shane E
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4208-14. PubMed ID: 26358172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?
    Hadji P; Gnant M; Body JJ; Bundred NJ; Brufsky A; Coleman RE; Guise TA; Lipton A; Aapro MS
    Cancer Treat Rev; 2012 Oct; 38(6):798-806. PubMed ID: 22429722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women.
    Peris P; Guañabens N; Martínez de Osaba MJ; Monegal A; Alvarez L; Pons F; Ros I; Cerdá D; Muñoz-Gómez J
    Semin Arthritis Rheum; 2002 Aug; 32(1):64-70. PubMed ID: 12219322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women.
    Vartej P; Poiana C; Vartej I
    Gynecol Endocrinol; 2001 Feb; 15(1):43-7. PubMed ID: 11293923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study.
    Tuppurainen M; Honkanen R; Kröger H; Saarikoski S; Alhava E
    Maturitas; 1993 Sep; 17(2):89-100. PubMed ID: 8231907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
    Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
    N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.